Updated Information On Birth Control Risk

yaz-warning, yasmin-warnings, ocella-warnings/Drug Recalls/ Maher Law Firm

Revised Drug Labels for Yaz and Yasmin The FDA recently issued a Drug Safety Communication informing the public it has completed a review study of the risk of blood clots in women taking birth control containing dropsirenone.  Drospirenone is a synthetic form of the female hormone progesterone, and is also called progestin.  The study concludes [...]

FDA Will Soon Decide Fate of Yaz and Other Drospirenone-Containing Birth Control Pills


The fate of Bayer’s highly-controversial birth control pill, Yaz, is in the hands of the U.S. Food and Drug Administration. The regulatory agency will meet on December 8th in order to determine whether or not the drug should be allowed to stay on the market. Following the analysis of data collected from an agency-funded study [...]

Study Confirms Drospirenone-Containing Birth Control Pills (YAZ and others) Increase Risk of VTE


According to a study published on October 25 in The British Medical Journal, newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Best-selling brands and generics like Yaz and Ocella are examples of the [...]

Drospirenone-Containing Birth Control Pills Still Under Scrutiny

Yaz Lawyer

In a new drug safety communication posted today on the U.S. Food and Drug Administration’s website, the agency announced that preliminary results of a study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. Popular [...]